Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NVD 003

Next Previous
Drug Profile

NVD 003

Alternative Names: NVD-003

Latest Information Update: 20 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novadip Biosciences
  • Class Stem cell therapies
  • Mechanism of Action Angiogenesis inducing agents; Cell replacements; Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pseudoarthrosis
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Pseudoarthrosis
  • Phase I/II Non-union fracture

Most Recent Events

  • 02 Sep 2025 Phase-III clinical trials in Pseudoarthrosis (In neonates, In infants, In children) in USA (Implant) (NCT07112443)
  • 08 Aug 2025 Novadip Biosciences plans a phase III trial for Pseudoarthrosis (In neonates, In infants, In children, In adolescents) in August 2025 (NCT07112443)
  • 23 Jun 2025 Novadip Biosciences plans a phase III trial for Pseudoarthrosis in USA and Europe, in June 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top